Physician profile
Luke Tp Vetti
NPI 1639431794
$3,812.44
in general payments reported to CMS, 2019-2025
31 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $116 · 2021: $325 · 2022: $713 · 2023: $796 · 2024: $495 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $413.35 | 2019-2023 | Krystexxa |
| Abbvie INC. | $369.72 | 2021-2024 | Dalvance |
| Organogenesis INC. | $292.14 | 2022-2025 | Novachor, Affinity, Cygnus Dual |
| Melinta Therapeutics, LLC | $284.53 | 2019-2022 | |
| Kerecis Limited | $280.98 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $249.30 | 2021-2024 | Prostep Mica |
| Paratek Pharmaceuticals, INC. | $222.96 | 2022-2023 | Nuzyra |
| Smith+Nephew, INC. | $166.19 | 2025 | Grafix, Stravix, Oasis |
| Convatec INC. | $160.76 | 2023 | |
| Anika Therapeutics, INC. | $155.70 | 2023 | Toe Motion, X-Twist, Syndez |
| Amgen INC. | $151.40 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $143.27 | 2022 | |
| Wright Medical Technology, INC. | $139.34 | 2019 | |
| In2bones USA, LLC | $110.13 | 2022 | |
| Abbott Laboratories | $102.94 | 2023 | Diamondback Peripheral |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $89.56 | 2019 | |
| Osteomed LLC | $80.08 | 2019 | |
| Globus Medical, INC. | $60.89 | 2025 | Senza |
| Bsn Medical INC | $52.91 | 2022 | |
| Lifenet Health | $42.85 | 2025 | Theragenesis Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $37.40 | 2025 | |
| Fortis Surgical, LLC | $30.54 | 2025 | |
| Omeza LLC | $29.53 | 2023 | |
| Medtronic, INC. | $26.35 | 2025 | Intellis Adaptivestim |
| Ani Pharmaceuticals, INC. | $26.18 | 2025 | Purified Cortrophin Gel |
| Osiris Therapeutics INC. | $20.21 | 2019 | |
| Depuy Synthes Sales INC. | $19.03 | 2019 | |
| Tactile Systems Technology INC | $14.51 | 2020 | |
| Bioventus LLC | $13.34 | 2023 | Exogen Ultrasound Bone Healing System |
| Linvatec Corporation | $13.32 | 2019 | |
| Forte Bio-Pharma LLC | $13.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Vetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.